首页|TIGIT、CD226、CD96和CD155在血小板糖蛋白自身抗体阳性的原发性免疫性血小板减少症的表达及临床意义

TIGIT、CD226、CD96和CD155在血小板糖蛋白自身抗体阳性的原发性免疫性血小板减少症的表达及临床意义

扫码查看
目的:探讨TIGIT、CD226、CD96和CD155在血小板糖蛋白自身抗体(platelet glycoprotein au-toantibody,GPs)阳性的原发性免疫性血小板减少症(immune thrombocytopenia,ITP)患者外周血CD8+T细胞和树突状细胞(dendritic cell,DC)膜表面的表达,并分析其临床意义.方法:选取41例GPs阳性的ITP患者和20例健康对照者,采用流式细胞术检测CD8+T细胞表面TIGIT、CD226和CD96表达比例,并检测ITP患者外周血DC细胞的亚群变化及浆细胞样DC(plasma DC,pDC)上 CD155的表达比例.结果:GPs阳性ITP组患者的pDC和CD155+pDC比例均明显高于对照组,且GPⅠ b/Ⅸ+/Ⅱ b/Ⅲa+/-组均明显高于GP Ⅰ b/Ⅸ-/Ⅱ b/Ⅲ a+组(P<0.05,F=40.83;P<0.01,F=59.50).GPs 阳性 ITP 组患者的 TIGIT+CD8+T 细胞比例明显低于对照组,且 GPⅠ b/Ⅸ+/Ⅱb/Ⅲa+/-组明显低于 GPⅠ b/Ⅸ-/Ⅱb/Ⅲa+组(P<0.05,F=36.41),但 CD226+CD8+T细胞与CD96+CD8+T细胞比例均明显高于对照组,且GP Ⅰ b/Ⅸ+/Ⅱ b/Ⅲ a+/-组均明显高于GPⅠ b/Ⅸ-/Ⅱb/Ⅲa+组(P<0.05,F=45.01;P<0.01,F=41.66).GPⅠ b/Ⅸ-/Ⅱb/Ⅲa+组与 GPⅠ b/Ⅸ+/Ⅱ b/Ⅲ a+/-组的CD155+pDC 与 TIGIT+CD8+T 细胞比例呈负相关(P<0.01,r=-0.54;P<0.01,r=-0.76),与 CD226+CD8+T 细胞和 CD96+CD8+T 细胞比例呈正相关(P<0.05,r=0.61;P<0.05,r=0.51;P<0.01,r=0.79;P<0.01,r=0.73).结论:TIGIT、CD226、CD96与CD155表达异常,导致GPs阳性的ITP的免疫失耐受,可能参与了疾病发生.
Expression and clinical significance of TIGIT,CD226,CD96,and CD155 in platelet glycoprotein autoantibody-positive primary immune thrombocytopenia
Objective:To investigate the expression of TIGIT,CD226,CD96 and CD155 on CD8+T cells and dendritic cells(DC)in the peripheral blood of patients with platelet glycoprotein autoantibody(GPs)-positive pri-mary immune thrombocytopenia(ITP)and to analyze their clinical significance.Methods:Forty-one GP-positive ITP patients and 20 healthy individuals were selected.The flow cytometry was used to detect the percentage of TIGIT,CD226,and CD96 expression on CD8+T cells and the changes in DC cell subsets and the percentage of CD155 expression on plasma DC(pDC)were analyzed.Results:The percentage of pDC and CD155+pDC in the GPs-positive ITP group were significantly higher than those in the healthy control group,and they were signifi-cantly higher in the GP I b/Ⅸ+/Ⅱ b/Ⅲ a+/-group than those in the GP Ⅰ b/Ⅸ-/11 b/Ⅲ a+group(P<0.05,F=40.83;P<0.01,F=59.50).On the other hand,the percentage of TIGIT+CD8+T cells in the GPs-positive ITP group was significantly lower than that in the healthy control group,and it was significantly lower in the GP Ⅰ b/Ⅸ+/Ⅱ b/Ⅲ a+/-group than that in the GP Ⅰ b/Ⅸ-/Ⅱ b/Ⅲ a+group(P<0.05,F=36.41).However,the per-centages of CD226+CD8+T cells and CD96+CD8+T cells were significantly higher than those in the control group,and they were significantly higher in the GP Ⅰ b/Ⅸ+/Ⅱ b/Ⅲ a+/-group than those in the GP Ⅰ b/Ⅸ-/Ⅱ b/Ⅲa+group(P<0.05,F=45.01;P<0.01,F=41.66).The percentages of CD155+pDC in the GP Ⅰ b/Ⅸ-/Ⅱ b/Ⅲa+group and GP Ⅰ b/Ⅸ+/Ⅱ b/Ⅲ a+/-group were negatively correlated with TIGIT+CD8+T cells(P<0.01,r=-0.54;P<0.01,r=-0.76),while it positively correlated with the percentages of CD226+CD8+T cells and CD96+CD8+T cells(P<0.05,r=0.61;P<0.05,r=0.51;P<0.01,r=0.79;P<0.01,r=0.73).Conclusion:The abnormal expression of TIGIT,CD226,CD96,and CD155 contributes to immune in-tolerance in GPs-positive ITP,which may be involved in the pathogenesis of the disease.

immune thrombocytopeniainhibitory moleculeCD226CD96

骆婷婷、张瑞、王秀娟、王璐、陈双

展开 >

新疆医科大学第一附属医院血液病中心实验室,新疆维吾尔自治区血液病研究所(乌鲁木齐,830054)

免疫性血小板减少症 抑制性分子 CD226 CD96

新疆维吾尔自治区自然科学基金青年基金

2022D01C754

2024

临床血液学杂志
华中科技大学同济医学院血液病研究所 北京医科大学血液病研究所

临床血液学杂志

CSTPCD
影响因子:1.063
ISSN:1004-2806
年,卷(期):2024.37(3)
  • 36